MDI/DPI Conference Results Featured in Respiratory Care Journal
For Immediate Release
IRVING, TX (September 1, 2005) – Aerosol drug therapy is quickly moving from a modality aimed solely at the delivery of bronchodilators and steroids for airway diseases to one used for everything from the administration of drugs to fight infections to the delivery of insulin.
Keeping up with the changing face of aerosol therapy is challenging for professionals, but the September and October issues of the American Association for Respiratory Care's peer-reviewed journal Respiratory Care provide the state-of-the-art information clinicians need to understand developments in this area and how they will impact patients.
Based on the April 2005 Journal Conference on “Metered-Dose Inhalers (MDIs) and Dry Powder Inhalers (DPIs) in Aerosol Therapy,” these two cutting edge editions of the journal provide a complete overview of current and future MDI/DPI technologies. The conference specifically addressed the following concerns:
- Factors involved in delivery and deposition of aerosols, including aerosol characteristics (size, physical properties, velocity, carrier), device properties (efficiency, reliability), airway/lung anatomy, and breathing pattern.
- Assessment techniques to evaluate aerosol delivery/deposition (e.g., in vitro models, computer models, physiologic effects, imaging, pharmacokinetics/pharmacodynamics).
- Pharmacology of both current and emerging new drugs for aerosol applications, with the required aerosol properties for each.
- New and emerging design features for MDI and DPI devices.
The resulting articles cover all of these issues in detail, with contributions from leading physicians and respiratory therapists in the field, including Paula J. Anderson MD; Bruce K. Rubin MEngr MD MBA FAARC, and James B. Fink MSc RRT FAARC; Chet L. Leach PhD DABT; and Martin J. Telko and Anthony J. Hickey PhD DSc.
Co-chairing the conference were Rajiv Dhand MD and Neil R. MacIntyre MD FAARC. In a foreword to the September issue, they write, “The result of this conference is a comprehensive collection of state-of-the-art reviews that should serve as an important reference for all clinician/scientists involved in aerosolized drug therapy.”
Respiratory Care is available on the web at www.rcjournal.com . Members of the American Association for Respiratory Care and subcribers to the journal receive access to the online publication; others may purchase access to the articles.
Journal Conferences are convened regularly by the American Respiratory Care Foundation to explore issues of key concern to the respiratory care and pulmonary medicine communities. Past topics have ranged from “Sleep Disordered Breathing” and “Transtracheal Gas Insufflation” to “Liquid Nebulization: Emerging Technologies” and “Evidence-Based Medicine in Respiratory Care.”
Respiratory Care journal is a peer-reviewed scientific journal published by the American Association for Respiratory Care (AARC) and listed in Index Medicus. The AARC is a professional membership organization of respiratory therapists dedicated to respiratory therapy education and research. Among its goals are to advocate on behalf of pulmonary patients for appropriate access to respiratory services provided by qualified professionals and to benefit respiratory health care providers.
###
Contact: Beth Binkley
Binkley@aarc.org
American Association For Respiratory Care
9425 N MacArthur Blvd, Suite 100, Irving, TX 75063
972-406-4657, 927-243-2272
